BE847343A - Antigene d'hepatite a, - Google Patents

Antigene d'hepatite a,

Info

Publication number
BE847343A
BE847343A BE171553A BE171553A BE847343A BE 847343 A BE847343 A BE 847343A BE 171553 A BE171553 A BE 171553A BE 171553 A BE171553 A BE 171553A BE 847343 A BE847343 A BE 847343A
Authority
BE
Belgium
Prior art keywords
hepatitis
antigen
Prior art date
Application number
BE171553A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE847343A publication Critical patent/BE847343A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BE171553A 1975-10-16 1976-10-15 Antigene d'hepatite a, BE847343A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/623,184 US4017601A (en) 1975-10-16 1975-10-16 Hepatitis A antigen

Publications (1)

Publication Number Publication Date
BE847343A true BE847343A (fr) 1977-04-15

Family

ID=24497099

Family Applications (1)

Application Number Title Priority Date Filing Date
BE171553A BE847343A (fr) 1975-10-16 1976-10-15 Antigene d'hepatite a,

Country Status (7)

Country Link
US (1) US4017601A (fr)
JP (2) JPS5251019A (fr)
BE (1) BE847343A (fr)
DE (1) DE2646625A1 (fr)
FR (1) FR2327999A1 (fr)
GB (1) GB1526529A (fr)
NL (1) NL188982C (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296024A (en) * 1974-12-09 1981-10-20 Merck & Co., Inc. Human immune serum globulin with high hepatitis A antibody titer
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
JPH0751513B2 (ja) * 1988-04-28 1995-06-05 国立予防衛生研究所長 Ａ型肝炎ワクチン
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US6063038A (en) * 1999-04-09 2000-05-16 Clmp, Inc. Devices and methods for collecting fecal antigen specimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen

Also Published As

Publication number Publication date
FR2327999B1 (fr) 1981-11-27
JPS5251019A (en) 1977-04-23
GB1526529A (en) 1978-09-27
FR2327999A1 (fr) 1977-05-13
DE2646625C2 (fr) 1988-03-31
JPS6242890B2 (fr) 1987-09-10
JPH0541609B2 (fr) 1993-06-24
NL188982C (nl) 1992-12-01
NL188982B (nl) 1992-07-01
NL7610657A (nl) 1977-04-19
DE2646625A1 (de) 1977-04-28
US4017601A (en) 1977-04-12
JPS62281822A (ja) 1987-12-07

Similar Documents

Publication Publication Date Title
BE835473A (fr) Serrure a tiges d'arret
FR2345586A1 (fr) Pot d'echappement
BE841586A (fr) Piece nodale d'assemblage
FR2312248A1 (fr) 1,3,-dihydroimidazo 4,5,-b pyridin-2-ones
IT7848873A0 (it) Antigene nucleo per epatite b
FR2349730A1 (fr) Pot d'echappement
BE836390A (fr) Antigene de l'hepatite a.
BE846054A (fr) Recuperation d'alkylene-glycols
NL7608711A (nl) Thermoplastische vormmassa's.
IT1060179B (it) Struttura a ciclone
BE847343A (fr) Antigene d'hepatite a,
FR2297628A1 (fr) 2,3-dihydroergolines
FR2325934A1 (fr) Methode de detection de la presence d'un antigene associe a l'hepatite
BE837598A (fr) TERPOLYMERES DE STYRENE, d'ISOBUTYLENE ET DE BETA-PINENE
SE7608452L (sv) 2,4-diamino-5-benzylpyrimidiner
FR2351999A1 (fr) Steroido (16a, 17-c) (2h)pyrroles anti-inflammatoires
SE7608417L (sv) 2-klor-n-isopropyl-2',3'-dimetylacetanilid
IT1054687B (it) Valvola a farfalla
BE844697A (fr) Ar-octahalodiphenyl-ether-4,4'-dimethanol
FR2325424A1 (fr) Reacteur a chauffage par l'helium
NL7604294A (nl) N'-sulfonyl-n"-dihalogeenfenylimidazolidinedion- -derivaten.
FR2327797A2 (fr) Modification antigene de polypeptides
IT1077596B (it) 1,3-diidro-1'-dimetilfosfinilalchil-3-fenilspiro isobenzofurani
FR2330405A1 (fr) 1'h-androsta (16,17) cyclopentene-3'-ones
SE7601455L (sv) 1,3-dialkyl-7-oxoalkylxantiner

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MERCK & CO. INC.

Effective date: 19931031